Reply from authors re: Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift

Nizar M. Tannir, Peter Thall, Randall E. Millikan

Research output: Contribution to journal › Editorial › peer-review

Fingerprint

Dive into the research topics of 'Reply from authors re: Camillo Porta. How to identify active novel agents in rare cancers and then make them available: A need for a paradigm shift. Eur Urol 2012;62:1020-1: Research in rare tumors: A need for a paradigm shift'. Together they form a unique fingerprint.